H2WIN has developed pragmatic renewable solutions using the core enzyme technology that has been recently Nobel Prized
Elaboration of a technical-scientific file
Creation of H2life
Photonics patent filing and foundation of H2WIN
New investment from the shareholders
Completion of the coupling between the photoanode and the enzymatic cathode
Start of the technological development phase
Association of enzymes at electrochemical interfaces
Development of core enzymes and corresponding patent registration
Demonstration of the superior performance of Corenzymes compared to the Platinum
- The 2021 Nobel Prize in Chemistry was awarded on the 6th of October in Stockholm to the German Benjamin List and the British David MacMillan for having developed a new tool for building molecules, called "asymmetric organo-catalysis".
- The two researchers have been honoured for independently developing a third type of catalysis in a field that has developed at a prodigious rate in recent years.
- The Nobel Prize in Chemistry was awarded this year to celebrate the third way of catalysis.
- The asymmetric organo-catalysis concept is the one of "core enzymes" such as H2WIN has been working on for several years (patent filed in 2019 for Hydrogenase).
The value of H2GREEN has been recognised by the scientific community. For example, the reputable scientific journals MRS Cambridge and Springer Nature published an article presenting the H2GREEN technology: ”The sustainable integration of human activities into the global ecosystem.” In this article, Dr Philippe Lorge discusses: the impact of waste heat on climate change; the urgent need to shift from the "thermal age" to an "electroprotonic era"; the importance of technical solutions based on biomimicry such as the H2GREEN system; and the construction of a new socio-economic model.